Silvia Menéndez Selected Research

Silvia Menéndez Research Topics

Disease

9	Neoplasms (Cancer) 12/2021 - 05/2009
6	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2015 - 07/2014
2	Acute Kidney Injury (Acute Renal Failure) 02/2009 - 02/2004
2	Shock 02/2005 - 01/2004
1	Adenoma (Adenomas) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Pathologic Complete Response 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2018
1	Mycosis Fungoides 10/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2018
1	Lymphoma (Lymphomas) 10/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017
1	Arthritis (Polyarthritis) 08/2013
1	Inflammation (Inflammations) 08/2013
1	Onychomycosis (Tinea Unguium) 09/2011
1	Pulmonary Emphysema 04/2011
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Ischemia 01/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2006
1	Necrosis 08/2006
1	Type 2 Diabetes Mellitus (MODY) 10/2005
1	Diabetic Foot 10/2005
1	Pathologic Processes 12/2004
1	Reperfusion Injury 04/2002

Drug/Important Bio-Agent (IBA)

11	OzoneIBA 08/2013 - 04/2002
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 05/2009
3	AntioxidantsIBA 08/2006 - 02/2005
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2019
2	CateninsIBA 10/2021 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2006
2	Phosphotransferases (Kinase)IBA 10/2018 - 05/2009
2	B7-H1 AntigenIBA 01/2018 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 08/2006 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2005 - 01/2004
1	MTOR InhibitorsIBA 01/2022
1	Everolimus FDA Link 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	urelumabIBA 12/2021
1	Interleukin-2 (IL2)IBA 12/2021
1	Granzymes (Granzyme)IBA 12/2021
1	beta CateninIBA 10/2021
1	Formaldehyde (Formol)FDA Link 02/2021
1	ParaffinIBA 02/2021
1	Amyloid beta-PeptidesIBA 01/2020
1	Free RadicalsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	serabelisibIBA 01/2019
1	sapanisertibIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2018
1	Programmed Cell Death 1 ReceptorIBA 11/2017
1	Immune Checkpoint InhibitorsIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Angiopoietin-2IBA 11/2015
1	onartuzumabIBA 06/2015
1	Therapeutic UsesIBA 02/2015
1	Estrogens (Estrogen)FDA Link 02/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2015
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2014
1	methionylmethionine (Met-Met)IBA 07/2014
1	CytokinesIBA 08/2013
1	Sunflower OilIBA 09/2011
1	Ketoconazole (Nizoral)FDA LinkGeneric 09/2011
1	Oxygen (Dioxygen)IBA 04/2011
1	Mitogen-Activated Protein KinasesIBA 05/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2009
1	N 30IBA 05/2009
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2008
1	EnzymesIBA 08/2006
1	CreatinineIBA 08/2006
1	Glutathione (Reduced Glutathione)IBA 08/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2005
1	Superoxides (Superoxide)IBA 10/2005
1	LipopolysaccharidesIBA 02/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2004

Therapy/Procedure

8	Therapeutics 01/2020 - 12/2004
2	Drug Therapy (Chemotherapy) 01/2019 - 02/2004
1	Immunotherapy 12/2021
1	Aftercare (After-Treatment) 01/2019
1	Liver Transplantation 01/2008